Results 301 to 310 of about 81,713 (355)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study

Pediatric Blood &Cancer, Volume 72, Issue 5, May 2025.
ABSTRACT Background and Aims Invasive fungal diseases (IFD) in children with newly diagnosed acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) are poorly characterized, especially in lower–middle‐income countries (LMICs). This study aims to identify the incidence, risk factors, and outcomes of IFD in a pediatric cohort with ALL/LBL ...
Amrutha Narayana Murthy, Shyam Srinivasan, Vasundhara Patil, Gaurav Salunke, Chetan Dhamne, Nirmalya Roy Moulik, Maya Prasad, Badira C Parambil, Venkata Rama Mohan Gollamudi, Akanksha Chichra, Girish Chinnaswamy, Gaurav Narula, Shripad Banavali   +12 more
wiley   +1 more source

Treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia. [PDF]

Medicine (Baltimore)
Kim J, Byun JM, Hong J, Koh Y, Shin DY, Kim TM, Yoon SS, Park H, Kim I.   +8 more
europepmc   +1 more source

Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

Clinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactions.
Claire Moore, Andreas Halman, Tayla Stenta, Dhrita Khatri, Elizabeth Williams, Roxanne Dyas, Julian Stolper, David A. Elliott, Rachel Conyers   +8 more
wiley   +1 more source

Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. [PDF]

Cancer Med
Ishida H, Imamura T, Kobayashi R, Hashii Y, Deguchi T, Miyamura T, Oda M, Yamamoto M, Okada K, Sano H, Koh K, Yuza Y, Watanabe K, Nishimura N, Takimoto T, Moriya-Saito A, Sekimizu M, Suenobu S, Sunami S, Horibe K.   +19 more
europepmc   +1 more source

Gamma-delta T-cell acute lymphoblastic lymphoma/leukemia: a report of a rare entity. [PDF]

J Hematop
George GV, Kajstura M, Evans AG, Syposs CR.   +3 more
europepmc   +1 more source

Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. [PDF]

Biomedicines
Castellanos G, Pardo L, López A, Cornago J, López JL, de Las Heras A, Díaz FJ, Martínez de Bourio M, Castillo E, Llamas P, Solán L.   +10 more
europepmc   +1 more source

Philadelphia Chromosome as a Clinically Favorable Prognostic Factor of B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Transplant-Ineligible Elderly Patients in the Era of Molecular-Targeted Therapy. [PDF]

Cureus
Saburi M, Nishikawa T, Maehara K, Uraisami K, Takata H, Miyazaki Y, Narahara K, Sasaki H, Abe M, Kohno K, Nakayama T, Ohtsuka E.   +11 more
europepmc   +1 more source

Dysuria and Vaginal Pain, Unusual Manifestations of B-acute Lymphoblastic Lymphoma. [PDF]

Clin Pathol
Mitra AD, Mitra A, Chung JH, Betts EV.
europepmc   +1 more source

T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation. [PDF]

Cancer Cell
Feng H, Stachura DL, White RM, Gutierrez A, Zhang L, Sanda T, Jette CA, Testa JR, Neuberg DS, Langenau DM, Kutok JL, Zon LI, Traver D, Fleming MD, Kanki JP, Look AT.   +15 more
europepmc   +1 more source

T-cell Lymphoblastic Lymphoma Unveiling As Superior Vena Cava Syndrome in a 19-Year-Old Male. [PDF]

Cureus
Gemnani R, Saboo K, Patil R, Kumar S, Acharya S.   +4 more
europepmc   +1 more source